News Room

Kintor Pharmaceutical Ltd, invested by Shanghai FTZ Fund, officially listed on HKEX

2020-05-22

On May 22, 2020, Kintor Pharmaceutical Ltd. (Stock Code: 9939.HK) invested by Shanghai FTZ Fund, has officially been listed on the main board of Hong Kong Stock Exchange(HKEX). Kintor was established in 2009, focusing on the development and industrialization of potential "best in class" and "first in class" innovative drugs, and is committed to becoming a leading enterprise in the research, development and commercialization.

SHFTZFUND won multiple awards including ‘PEAS Best Investment Institution’ in 2023.

Shanghai FTZ Fund successfully holds the "Lingang Industry Salon" for Spatial Information Industry

This activity is a brand series of activities held by Shanghai FTZ Fund and its Lingang Special Area Sci-tech Innovation Fund on a regular basis.

Shanghai FTZ Fund receives China Bridge 2023 Annual Awards

Lately, Shanghai FTZ Fund has been awarded China Bridge "2023 Top 50 Private Equity Investment Institutions in China" and "2023 Best Chinese Capital Investment Institution".

Shanghai FTZ Fund awarded ZERO2IPO 2023 "Chinese State-owned Capital Investment Institutions Top50"

Today, ZERO2IPO published "China Venture Capital & Private Equity Annual Ranking 2023", and Shanghai FTZ Fund has been awarded 2023 "Chinese State-owned Capital Investment Institutions Top50"

Shanghai FTZ Fund
Wechat Official Account